Lexeo Therapeutics (LXEO) Prepaid Assets (2022 - 2026)
Lexeo Therapeutics (LXEO) reported Prepaid Assets of $7.8 million for Q1 2026, up 43.65% on a YoY basis from $5.4 million in Q1 2025, and up 18.02% sequentially from $6.6 million in Q4 2025.
Lexeo Therapeutics (LXEO) Prepaid Assets (2022 - 2026) Analysis & Trends
Lexeo Therapeutics (LXEO) has 5 years of Prepaid Assets data on file, last reported at $7.8 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 43.65% year-over-year to $7.8 million; the trailing twelve-month figure through Mar 2026 stood at $7.8 million (up 43.65% YoY), and the FY2025 full-year result was $6.6 million, up 43.93% from the prior year.
- Prepaid Assets improved to $7.8 million in Q1 2026, from $6.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $7.8 million in Q1 2026 to a low of $1.4 million in Q3 2023.
- A 5-year average of $4.2 million and a median of $3.8 million in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets advanced 20.75% in 2023 and surged 230.67% in 2025, its largest moves.
- Tracing LXEO's Prepaid Assets over 5 years: stood at $2.3 million in 2022, then increased by 20.75% to $2.8 million in 2023, then soared by 62.77% to $4.6 million in 2024, then jumped by 43.93% to $6.6 million in 2025, then gained by 18.02% to $7.8 million in 2026.
- Business Quant data shows LXEO's Prepaid Assets at $7.8 million in Q1 2026, $6.6 million in Q4 2025, and $5.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Lexeo Therapeutics | 382.38 Mn | 382.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.82 Mn |
| Dec 31, 2025 | 6.63 Mn |
| Sep 30, 2025 | 5.03 Mn |
| Jun 30, 2025 | 7.17 Mn |
| Mar 31, 2025 | 5.44 Mn |
| Dec 31, 2024 | 4.60 Mn |
| Sep 30, 2024 | 2.44 Mn |
| Jun 30, 2024 | 2.17 Mn |
| Mar 31, 2024 | 3.03 Mn |
| Dec 31, 2023 | 2.83 Mn |
| Sep 30, 2023 | 1.41 Mn |
| Dec 31, 2022 | 2.34 Mn |